Catheter Precision (VTAK) Shareholder's Equity Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Catheter Precision | 2.01 Mn | 1.20 Mn | 390,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.88% |
| Dec 31, 2025 | -43.43% |
| Sep 30, 2025 | -47.12% |
| Jun 30, 2025 | -54.26% |
| Mar 31, 2025 | -57.27% |
| Dec 31, 2024 | -44.52% |
| Sep 30, 2024 | -41.35% |
| Jun 30, 2024 | -39.82% |
| Mar 31, 2024 | -48.35% |
| Dec 31, 2023 | 128.87% |
| Sep 30, 2023 | 74.80% |
| Jun 30, 2023 | 142.99% |
| Mar 31, 2023 | 98.05% |
| Dec 31, 2022 | -32.28% |
| Sep 30, 2022 | -41.95% |
| Jun 30, 2022 | -53.95% |
| Mar 31, 2022 | 19.56% |
| Dec 31, 2021 | -35.34% |
| Sep 30, 2021 | -29.44% |
| Jun 30, 2021 | -21.20% |
| Mar 31, 2021 | -42.79% |
| Dec 31, 2020 | -36.21% |
| Sep 30, 2020 | -26.84% |
| Jun 30, 2020 | -48.00% |
| Mar 31, 2020 | -55.73% |
| Dec 31, 2019 | -50.32% |
| Sep 30, 2019 | 544.05% |
| Jun 30, 2019 | 430.73% |
| Mar 31, 2019 | 771.35% |
| Dec 31, 2018 | 976.24% |